FDA Announces Approval of Information Collection for Prescription Drug Advertisements

Summary

The Food and Drug Administration (FDA) has received approval from the Office of Management and Budget (OMB) to collect information on experimental variations in direct-to-consumer print advertisements for prescription drugs, as required by the Paperwork Reduction Act of 1995.